Back to dashboard
CommercialCoverageMedium impact

Retinal Telescreening for Diabetic Retinopathy

Blue Cross & Blue Shield of Mississippi·MS · Family Medicine, Internal Medicine, Endocrinology +2 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

BCBS Mississippi now covers retinal telescreening for diabetic retinopathy screening using digital imaging with manual interpretation or FDA-approved AI software (IDx-DR, EyeArt). The policy clarifies that telescreening is only for screening, not for monitoring or managing existing diabetic retinopathy cases.

Action Required

Action needed
Immediately: Billing team should verify that retinal telescreening claims for diabetic patients specify screening indication only (not monitoring/management of existing retinopathy). Update prior authorization processes to ensure digital retinal imaging uses FDA-approved AI systems when applicable. Providers must document that telescreening is for screening purposes in diabetic patients without prior retinopathy diagnosis.